Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients
Katarina Mirjačić Martinović, Nada Babović, Radan Džodić, et al.
Melanoma Research (2014) Vol. 24, Iss. 4, pp. 295-304
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
Bin Han, Fangyuan Mao, Yongliang Zhao, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 102
Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
Daria S. Chulpanova, Kristina V. Kitaeva, Andrew R. Green, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 92
Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
Kaat de Jonge, Anna Ebering, Sina Nassiri, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients
Kawaljit Kaur, Jessica Cook, So‐Hyun Park, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 64
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia‐Kubik
Cells (2021) Vol. 10, Iss. 6, pp. 1420-1420
Open Access | Times Cited: 51
Memory-like Differentiation Enhances NK Cell Responses to Melanoma
Nancy D. Marín, Bradley A. Krasnick, Michelle Becker‐Hapak, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 17, pp. 4859-4869
Open Access | Times Cited: 51
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
Elena Shklovskaya, Helen Rizos
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6741-6741
Open Access | Times Cited: 42
Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
Sandra Weil, Stefanie Memmer, Axel Lechner, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 50
Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
Hansol Lee, Inês Pires da Silva, Umaimainthan Palendira, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1363-1363
Open Access | Times Cited: 36
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity
Yulian Xu, Xueli Sun, Yunguang Tong
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
Raquel Tarazona, Esther Durán, Rafael Solana
Frontiers in Immunology (2016) Vol. 6
Open Access | Times Cited: 47
Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients
Katarina Mirjačić Martinović, Nada Babović, Radan Džodić, et al.
Journal of Translational Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 43
NK‐ and T‐cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti‐CTLA‐4 therapy
Rosa Sottile, Milad Tannazi, Maria H. Johansson, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 8, pp. 2238-2248
Open Access | Times Cited: 37
ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
Kawaljit Kaur, Tahmineh Safaie, Meng-Wei Ko, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 239-239
Open Access | Times Cited: 29
Identification of Natural Killer Cell‐Associated Clusters in Skin Melanoma and the Impact on Prognosis and Drug Sensitivity
Jun Zhou, Renhui Cai, Danqun Zhang, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 2
Open Access
Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice
Kawaljit Kaur, Hui-Hua Chang, Paytsar Topchyan, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 36
Dendritic cell regulation of NK‐cell responses involves lymphotoxin‐α, IL‐12, and TGF‐β
Dhifaf Sarhan, Marzia Palma, Yumeng Mao, et al.
European Journal of Immunology (2015) Vol. 45, Iss. 6, pp. 1783-1793
Open Access | Times Cited: 34
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
Kawaljit Kaur, Meng-Wei Ko, Nick Ohanian, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 29
NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma
Cinzia Garofalo, Carmela De Marco, Costanza Maria Cristiani
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Natural killer cell receptors: alterations and therapeutic targeting in malignancies
Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović
Immunologic Research (2015) Vol. 64, Iss. 1, pp. 25-35
Closed Access | Times Cited: 33
Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model
Shintaro Ishikawa, Takako Ishikawa, Chiaki Tezuka, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, pp. 1-8
Open Access | Times Cited: 30
The role of the natural killer (NK) cell modulation in breast cancer incidence and progress
Ehsan Razeghian, Mahdis Chahar Kameh, Sepehr Shafiee, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10935-10948
Closed Access | Times Cited: 15
Critical roles of co‐activation receptor DNAX accessory molecule‐1 in natural killer cell immunity
Xiong Peng, Haiwei Sang, Min Zhu
Immunology (2015) Vol. 146, Iss. 3, pp. 369-378
Open Access | Times Cited: 27
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma
Nicolas Jacquelot, Jonathan M. Pitt, David Enot, et al.
OncoImmunology (2017) Vol. 6, Iss. 8, pp. e1299303-e1299303
Open Access | Times Cited: 26
Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies
Surojit Karmakar, Pradipta Pal, Girdhari Lal
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 387-407
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top